safety of glp 1 receptor agonists GLP-1 and the Eye: Evidence, Mechanisms, and Clinical Guidance ๐๏ธ๐ Overview of GLP-1 Receptor Agonist
Description
Ruff, C

Under an FDA policy, these companies can sometimes produce and dispense compounded drugs with fewer regulations and restrictions in times of shortages
Prescribing information (Eli Lilly, 2025)

Roglic, G., Unwin, N., Bennett, P

A., Meier, J